title: Inhibition of murine sarcoma cell adherence to polystyrene substrata by bacillus Calmette-Guérin: evidence for fibronectin-mediated direct antitumor activity of BCG.
abstract: Bacillus Calmette-Guérin (BCG) inhibited adherence of S180 mouse sarcoma cells and WI38 human diploid fibroblasts to the polystyrene substratum of 24-well cluster dishes in a dose-dependent manner. This property was retained by washed or heat-killed bacilli, but not by the vaccine filtrate or by the spent bacterial culture medium. Adhesion of bacilli to nonadherent S180 cells was demonstrated by light and scanning electron microscopy, but was not seen after trypsinization of adherent cells, indicating that bacilli bind to cell-surface adhesins. Preincubation of bacilli with human fibronectin abolished their ability to inhibit S180 adherence, suggesting that the phenomenon may be mediated by interaction of bacilli with cell-surface fibronectin. Fibronectin pretreatment of the bacteria also decreased their inhibition of S180 tumor growth in vivo, indicating that this mechanism may be at least partly responsible for BCG vaccine's observed antineoplastic activity.
authors.affiliation: Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago.
authors.forename: M E
authors.initials: ME
authors.lastname: Klegerman
authors.forename: P L
authors.initials: PL
authors.lastname: Zeunert
authors.forename: Y
authors.initials: Y
authors.lastname: Lou
authors.forename: P O
authors.initials: PO
authors.lastname: Devadoss
authors.forename: M J
authors.initials: MJ
authors.lastname: Groves
mesh_terms: D000327:Adsorption / Q000187:drug effects; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001500:BCG Vaccine / Q000493:pharmacokinetics / Q000494:pharmacology*; D002448:Cell Adhesion / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D005353:Fibronectins / Q000502:physiology*; D006801:Humans; D051379:Mice; D011137:Polystyrenes; D012510:Sarcoma 180 / Q000188:drug therapy* / Q000473:pathology*; D014357:Trypsin / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D001500:BCG Vaccine; D005353:Fibronectins; D011137:Polystyrenes; D014357:Trypsin